Verified July 2026 · Cited to primary sources

Peptide therapy in 2026: what it is, what works, and how to access it legally

Peptide therapy is the supervised use of peptides for goals like recovery, growth-hormone support, and anti-aging. The honest reality: of the 14 peptides used this way that we grade, only 2 is FDA-approved and 6rest on animal data alone. Most “therapy” is not FDA-approved.

What is peptide therapy?

Peptide therapy means using specific peptides — short chains of amino acids that act as signaling molecules — under medical supervision to pursue a goal like injury recovery, muscle and growth-hormone support, fat loss, sleep, or skin and anti-aging. In practice it is delivered through a telehealth platform or a compounding pharmacy, usually as a subcutaneous injection prescribed after a consult. If you are new to the molecules themselves, start with what are peptides.

The word “therapy” does a lot of quiet work in the marketing. It implies an approved, evidence-backed medical treatment. For a handful of peptides that is true. For most, “peptide therapy” describes the off-label or unapproved use of a research compound — which is exactly why the evidence question below matters more than any clinic's brochure.

What does the evidence actually say?

This is the honest core of the page. We grade every peptide A–F by the strength of its human evidence, using a fixed decision tree — never by how it is marketed or whether we can monetize it. Here are the peptides actually used in therapy, ranked best-evidenced to least, with their legal status and primary use:

PeptideEvidenceLegal statusPrimary use
TesamorelinAFDA-approved / proven in humansFDA-approved (Rx)Weight Loss
SermorelinBReal human trials, limited or historicalLegal via 503AMuscle Growth
RetatrutideBReal human trials, limited or historicalResearch-onlyWeight Loss
GHK-CuBReal human trials, limited or historicalLegal topicalSkin & Anti-Aging
SemaxCEarly or foreign human data onlyUnder FDA reviewCognition & Focus
CJC-1295 / IpamorelinCEarly or foreign human data onlyResearch-onlyMuscle Growth
CJC-1295CEarly or foreign human data onlyResearch-onlyMuscle Growth
SelankCEarly or foreign human data onlyResearch-onlyCognition & Focus
BPC-157DAnimal studies only, unproven in humansUnder FDA reviewRecovery & Healing
TB-500DAnimal studies only, unproven in humansUnder FDA reviewRecovery & Healing
KPVDAnimal studies only, unproven in humansUnder FDA reviewRecovery & Healing
MOTS-cDAnimal studies only, unproven in humansUnder FDA reviewWeight Loss
EpitalonDAnimal studies only, unproven in humansUnder FDA reviewSleep
IGF-1 LR3DAnimal studies only, unproven in humansResearch-onlyMuscle Growth

The pattern is unmistakable: 6 of these peptides are Grade D — animal studies only — and only 2 reaches Grade A. The famous recovery peptides driving most of the demand (BPC-157, TB-500, KPV) all sit at Grade D. See exactly how the scale is built on how we grade evidence, the full A–F methodology and sortable lookup.

Is peptide therapy legal?

Partly. Legality is not one status — it is five, and where a peptide sits decides whether there is any lawful way to get it. Sermorelin is legally compounded through a 503A pharmacy because of its prior FDA approval, and FDA-approved peptides like tesamorelin and PT-141 are legal by prescription. Those are the legitimate lanes for supervised peptide therapy today.

The rest is the problem. The famous recovery peptides were removed from the FDA's 503A Category 2 bulk-substances list in April 2026 and are under review at the July 23–24, 2026 PCAC meeting — until that vote, there is no compliant supervised route, and a vial labeled “research use only” is a marketing fig-leaf, not a legal loophole. The full breakdown is on are peptides legal in 2026.

How much does peptide therapy cost, and where can you get it legally?

For the legally-accessible options, supervised sermorelin runs roughly $96–$225 per month through telehealth and $200–$400 per month through local clinics; FDA-approved branded peptides cost far more (Egrifta / tesamorelin commonly exceeds $3,000 per month at retail). We never quote or link gray-market vial pricing. Compare legal-access cost ranges side by side on the peptide cost comparator.

These are licensed telehealth and clinic routes that source the legally-accessible peptides (chiefly sermorelin) from regulated pharmacies. We list them because they are compliant — not because a peptide under FDA review has become legal:

Peter MDtelehealth

$90–$300 per program (Katalys CPA band)

Check Peter MD
Marek Healthtelehealth

Membership + labs; pricing varies by protocol

Check Marek Health
Maximustelehealth

$80–$290 per program (Katalys CPA band)

Check Maximus
Hone Healthtelehealth

$30–$75 per program (Katalys CPA band) + at-home labs

Check Hone Health
Ways2Welltelehealth

Protocol-based pricing; consult required

Check Ways2Well
Nava Healthclinic

Clinic consult + protocol; pricing varies

Check Nava Health
Telos RXtelehealth

Online prescription pricing; consult required

Check Telos RX

Editorial firewall: we never point to gray-market or “research use only” vendors, and no peptide under FDA review gets an access link here until its legal status clears. See our affiliate disclosure and editorial policy.

How are peptides prepared and dosed?

Most therapy peptides ship as a lyophilized (freeze-dried) powder that a pharmacy or clinician reconstitutes with bacteriostatic water before dosing — which is why so much of the community vocabulary is about reconstitution and concentration. We do not publish dosing protocols: that is a clinical decision for a licensed provider, and dosing advice on unapproved compounds is exactly the kind of YMYL risk this site avoids. If you simply want to understand the reconstitution math (powder + water → concentration per unit), the peptide calculator walks through it non-prescriptively.

What about peptide therapy for weight loss?

This is where the honest answer saves you money. No research peptide here beats an approved GLP-1 medication for weight loss. Tesamorelin (Grade A) is proven only for HIV-associated visceral fat, retatrutide (Grade B) is investigational and not legally available, and MOTS-c is Grade D. If weight loss is the actual goal, the evidence points to approved GLP-1 medications — and our sister site GLP-1 Picks compares the legitimate telehealth providers for those. See also the best peptides for weight loss verdict.

FAQ

Peptide therapy: common questions

What is peptide therapy?

Peptide therapy is the supervised use of specific peptides — short chains of amino acids that act as signaling molecules — for goals like recovery, growth-hormone support, or anti-aging, typically through a telehealth platform or compounding pharmacy. The honest catch: most peptides used this way are not FDA-approved, and their benefits are backed by animal data rather than human trials.

Does peptide therapy actually work?

It depends entirely on the peptide. A few have real human evidence — tesamorelin is FDA-approved and proven to cut visceral fat, and sermorelin has historical trial data. But most peptides marketed for therapy (BPC-157, TB-500, KPV, MOTS-c and others) are Grade D on our scale: animal studies only, unproven in humans. There is no single "peptide therapy works" answer — it's peptide-by-peptide.

Is peptide therapy legal?

Some of it. Sermorelin is legally compounded through a 503A pharmacy, and FDA-approved peptides like tesamorelin and PT-141 are legal by prescription. But the famous recovery peptides were removed from the FDA's 503A list in April 2026 and are under review at the July 23–24, 2026 PCAC meeting — until that vote, there is no compliant route, and vials sold "for research only" are a gray-market fig-leaf, not a legal loophole.

How much does peptide therapy cost?

For the legally-accessible options, sermorelin runs roughly $96–$225 per month through telehealth and $200–$400 per month through clinics. FDA-approved branded peptides are far more expensive — Egrifta (tesamorelin) commonly exceeds $3,000 per month at retail. We never quote gray-market vial pricing, because that supply is unregulated and off-limits editorially.

Is peptide therapy safe?

The best-studied peptides here have real human safety data; most do not. The larger, well-documented risk is the unregulated gray-market supply — FDA testing of compounded injectables has found dosing errors, impurities, and unapproved ingredient forms. The safest path is a licensed clinician sourcing from a regulated pharmacy, never a "research use only" vendor.

References

  1. FDA — Pharmacy Compounding Advisory Committee, July 23–24, 2026 meeting
  2. Federal Register — FDA-2025-N-6895 (April 2026 503A bulk-substances reclassification)
  3. FDA — 503A bulk drug substances list
  4. Drugs@FDA — FDA-approved drug approval records
  5. FDA — Concerns with unapproved GLP-1 drugs used for weight loss (dosing errors, impurities, unapproved salt forms in compounded injectables)
  6. Safety of Compounded Medications — review (NCBI/PMC); the 2001 FDA compounding survey found 31% of sampled products failed standard potency testing

The monthly peptide evidence brief.

What the research and the FDA actually say about peptide therapy — one short email a month. Unsubscribe anytime.

No spam. We never sell your email. Editorial policy.